Literature DB >> 3049658

Occurrence of mucoid M-18 Streptococcus pyogenes in a central Ohio pediatric population.

M J Marcon1, M M Hribar, D M Hosier, D A Powell, M T Brady, A C Hamoudi, E L Kaplan.   

Abstract

During a 1-year period from October 1986 through September 1987, we recovered 116 mucoid, hemolytic Streptococcus pyogenes isolates from clinical specimens collected from patients seen at our pediatric institution. A total of 102 isolates were from throat cultures (101 for pharyngitis, 1 for acute rheumatic fever), 13 were from other superficial body sites, and 1 was from pleural fluid. All of 40 mucoid isolates tested to date were determined to be M-type 18 strains. A direct latex agglutination test for group A carbohydrate antigen in throat swab specimens was equally sensitive in detecting M-18 mucoid and nonmucoid strains (45 of 77 [58%] and 795 of 1,186 [67%], respectively; not significant, P greater than 0.05). Antimicrobial susceptibility tests performed with 40 mucoid and 40 nonmucoid isolates against penicillin and nine other antimicrobial agents showed all strains to be susceptible, with no difference in MICs. All isolates tested were also considered fully susceptible to the bactericidal activity of penicillin. Further studies are needed to establish the relative virulence of M-18 strains and their possible association with the resurgence of acute rheumatic fever in central Ohio and other areas of the United States.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3049658      PMCID: PMC266656          DOI: 10.1128/jcm.26.8.1539-1542.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

Review 1.  Group A streptococcal infections of the skin and pharynx (second of two parts).

Authors:  G Peter; A L Smith
Journal:  N Engl J Med       Date:  1977-08-18       Impact factor: 91.245

2.  Significance of quantitative salivary cultures for group A and non-group A and non-group A beta-hemolytic streptococci in patients with pharyngitis and in their family contacts.

Authors:  E L Kaplan; R Couser; B B Huwe; C McKay; L W Wannamaker
Journal:  Pediatrics       Date:  1979-12       Impact factor: 7.124

3.  Outbreak of acute rheumatic fever in northeast Ohio.

Authors:  B Congeni; C Rizzo; J Congeni; V V Sreenivasan
Journal:  J Pediatr       Date:  1987-08       Impact factor: 4.406

4.  The group A streptococcal upper respiratory tract carrier state: an enigma.

Authors:  E L Kaplan
Journal:  J Pediatr       Date:  1980-09       Impact factor: 4.406

5.  An epidemic of pharyngitis due to a nonhemolytic group A streptococcus at lowry air force base.

Authors:  L James; R B McFarland
Journal:  N Engl J Med       Date:  1971-04-08       Impact factor: 91.245

6.  Acute rheumatic fever in western Pennsylvania and the tristate area.

Authors:  E R Wald; B Dashefsky; C Feidt; D Chiponis; C Byers
Journal:  Pediatrics       Date:  1987-09       Impact factor: 7.124

7.  Resurgence of acute rheumatic fever.

Authors:  D M Hosier; J M Craenen; D W Teske; J J Wheller
Journal:  Am J Dis Child       Date:  1987-07

8.  Resurgence of acute rheumatic fever in the intermountain area of the United States.

Authors:  L G Veasy; S E Wiedmeier; G S Orsmond; H D Ruttenberg; M M Boucek; S J Roth; V F Tait; J A Thompson; J A Daly; E L Kaplan
Journal:  N Engl J Med       Date:  1987-02-19       Impact factor: 91.245

9.  New approaches for the laboratory recognition of M types of group A streptococci.

Authors:  J Rotta; R M Krause; R C Lancefield; W Everly; H Lackland
Journal:  J Exp Med       Date:  1971-11-01       Impact factor: 14.307

  9 in total
  7 in total

1.  Heart valve structure: a predisposing factor for rheumatic heart disease.

Authors:  S Nayar; P G Nayar; K M Cherian
Journal:  Heart       Date:  2006-08       Impact factor: 5.994

2.  Parameters governing invasive disease propensity of non-M1 serotype group A streptococci.

Authors:  Peter G Maamary; Martina L Sanderson-Smith; Ramy K Aziz; Andrew Hollands; Jason N Cole; Fiona C McKay; Jason D McArthur; Joshua K Kirk; Amanda J Cork; Rachael J Keefe; Rita G Kansal; Hongmin Sun; William L Taylor; Gursharan S Chhatwal; David Ginsburg; Victor Nizet; Malak Kotb; Mark J Walker
Journal:  J Innate Immun       Date:  2010-09-02       Impact factor: 7.349

Review 3.  Molecular insight into invasive group A streptococcal disease.

Authors:  Jason N Cole; Timothy C Barnett; Victor Nizet; Mark J Walker
Journal:  Nat Rev Microbiol       Date:  2011-09-16       Impact factor: 60.633

4.  Capsular Polysaccharide of Group A Streptococcus.

Authors:  Michael R Wessels
Journal:  Microbiol Spectr       Date:  2019-01

5.  Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A Streptococcus.

Authors:  A E Moses; M R Wessels; K Zalcman; S Albertí; S Natanson-Yaron; T Menes; E Hanski
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

6.  Evaluation of bacterial interference and beta-lactamase production in management of experimental infection with group A beta-hemolytic streptococci.

Authors:  I Brook; J D Gilmore
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

7.  Critical role of the group A streptococcal capsule in pharyngeal colonization and infection in mice.

Authors:  M R Wessels; M S Bronze
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.